In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Ganga Pharmaceuticals has informed that it enclosed certificate received from its Registrar and Share Transfer Agent, KFIN Technologies confirming dematerialization of Shares, mutilation & cancellation of Share Certificates received for dematerialization during the quarter ended March 31, 2022.
The above information is a part of company’s filings submitted to BSE.